我们的发声
从此,不再为汇款费用而纠结
首页
-
了解我们
-
媒体报道
2026-08-24 20:35
Carlyle Stock Analysis 2024: Pandemic Impact, Risks, Liquidity, Valuation & Buybacks
Carlyle Stock Analysis 2024: Pandemic Impact, Risks, Liquidity, Valuation & Buybacks【carlyle stock】
完整阅读
2026-08-24 20:35
Carlyle Group Earnings, Risk Profile & Asset Allocation Analysis
Carlyle Group Earnings, Risk Profile & Asset Allocation Analysis【carlyle stock】
完整阅读
2026-08-24 20:35
30 Unique Carlyle Stock Questions: Ticker, CAGR, FRE, Dividends & ESG
30 Unique Carlyle Stock Questions: Ticker, CAGR, FRE, Dividends & ESG【carlyle stock】
完整阅读
2026-08-24 20:05
Carlyle Stock Analysis: Valuation Drivers and Investor Strategy
Carlyle Stock Analysis: Valuation Drivers and Investor Strategy【carlyle group lp stock】
完整阅读
2026-08-24 20:05
Carlyle’s 2022 C-Corp Shift: Impact on Valuation, EPS, and Index Inclusion
Carlyle’s 2022 C-Corp Shift: Impact on Valuation, EPS, and Index Inclusion【carlyle group lp stock】
完整阅读
2026-08-24 20:05
30 Insightful Questions on The Carlyle Group (CG) Stock: Dividends, FRE, AUM Mix, Performance & Valuation vs Peers
30 Insightful Questions on The Carlyle Group (CG) Stock: Dividends, FRE, AUM Mix, Performance & Valuation vs Peers【carlyle group lp stock】
完整阅读
2026-08-24 19:35
Carisma Therapeutics: Biomarkers, TME Modulation, SEC Risks, Cash Runway & CT-0508 R&D Analysis
Carisma Therapeutics: Biomarkers, TME Modulation, SEC Risks, Cash Runway & CT-0508 R&D Analysis【carisma therapeutics stock】
完整阅读
2026-08-24 18:35
30 Unique Caribou Stock Questions: IUCN Status, Genetics, Indigenous Monitoring & Recovery
30 Unique Caribou Stock Questions: IUCN Status, Genetics, Indigenous Monitoring & Recovery【caribou stock】
完整阅读
2026-08-24 18:05
Caribou Biosciences: Ownership, FDA Status, R&D Spend, Cash Runway & Secondary Offerings
Caribou Biosciences: Ownership, FDA Status, R&D Spend, Cash Runway & Secondary Offerings【caribou biosciences stock】
完整阅读
2026-08-24 18:05
Caribou Biosciences CRISPR Pipeline: Revenue, Clinical Progress, Chyron™, Trials & Partnerships
Caribou Biosciences CRISPR Pipeline: Revenue, Clinical Progress, Chyron™, Trials & Partnerships【caribou biosciences stock】
完整阅读
上一页
下一页
最新消息
ComBankEth’s ESG, Green Financing & Digital Innovation Strategy 2023–2028
2026-10-02 18:34
ComBankEth 2024 Transparency Report: Branches, ATMs, SME Loans, Credit Cards, NPLs, Fintech, HGERA & Digital Inclusion
2026-10-02 18:34
ComBankEth: National ID, AML/CFT, Financial Inclusion, Blockchain & ISO 27001 Since 2020
2026-10-02 18:34
ComBankEth Mobile Banking: Accounts, Fees, SWIFT Transfers & Abroad Opening
2026-10-02 18:34
更多